CAXTON CORP - ADDEX THERAPEUTICS LTD ownership

ADDEX THERAPEUTICS LTD's ticker is ADXN and the CUSIP is 00654J107. A total of 6 filers reported holding ADDEX THERAPEUTICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAXTON CORP ownership history of ADDEX THERAPEUTICS LTD
ValueSharesWeighting
Q1 2022$1,351,000
-19.2%
265,9400.0%1.68%
+22.8%
Q4 2021$1,673,000
-30.2%
265,9400.0%1.37%
-29.6%
Q3 2021$2,396,000
-5.7%
265,9400.0%1.94%
+11.5%
Q2 2021$2,542,000
-9.0%
265,9400.0%1.74%
-4.0%
Q1 2021$2,792,000
-21.7%
265,9400.0%1.81%
-18.4%
Q4 2020$3,564,000
+1573.2%
265,940
+1428.6%
2.22%
+1005.5%
Q3 2020$213,000
+40.1%
17,398
-0.1%
0.20%
+25.6%
Q2 2020$152,000
+32.2%
17,4180.0%0.16%
+27.0%
Q1 2020$115,00017,4180.13%
Other shareholders
ADDEX THERAPEUTICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 941,448$1,083,0000.06%
New Leaf Venture Partners, L.L.C. 50,000$58,0000.04%
ARMISTICE CAPITAL, LLC 253,017$291,0000.01%
OLD MISSION CAPITAL LLC 31,134$36,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
UBS Group AG 7,954$9,0000.00%
View complete list of ADDEX THERAPEUTICS LTD shareholders